Association of Acanthosis Nigricans and Insulin Resistance in Indian Children and Youth - A HOMA2-IR Based Cross-Sectional Study.
Acanthosis nigricans
HOMA2-IR
insulin resistance
Journal
Indian dermatology online journal
ISSN: 2229-5178
Titre abrégé: Indian Dermatol Online J
Pays: India
ID NLM: 101586880
Informations de publication
Date de publication:
Historique:
entrez:
1
6
2019
pubmed:
1
6
2019
medline:
1
6
2019
Statut:
ppublish
Résumé
The American Diabetes Association includes acanthosis nigricans (AN) as an indicator of diabetes mellitus risk in overweight youth entering puberty. Some argue that AN is not an independent predictor of insulin resistance (IR), when body mass index (BMI) is controlled for. There is a paucity of studies on the association of AN and IR among children and young adults from India. Homeostatic model assessment-IR (HOMA2-IR), a computerized updated model, which is supposed to be superior to HOMA1-IR, has rarely been used for quantification of IR. Sixty cases (irrespective of BMI), aged 2-24 years with AN, and 30 age- and sex-matched normal weight controls were included. A thorough clinical examination and grading of AN was done. BMI, fasting glucose levels, and fasting insulin levels were measured for all. HOMA-IR calculator V.2.2.3 was used to calculate IR. Those with HOMA 2-IR >1.8 were considered insulin-resistant. Lifestyle modifications were advised for patients with IR. The mean HOMA2-IR value in cases and controls was 2.422 and 1.322, respectively, which was statistically significant. Overweight and obese cases had 2.5 and 11.25 times higher risk of having IR, respectively, by logistic regression. The association of AN with IR was found to be statistically significant in normal weight cases when compared with controls ( The relatively small sample size may not reflect the accuracy of AN as a marker of IR. Acanthosis nigricans is associated with IR in both normal and obese. We propose that all children, adolescents, and youth with AN be screened for IR irrespective of BMI. Early identification and prompt lifestyle interventions may prevent or delay the onset of diabetes later.
Identifiants
pubmed: 31149570
doi: 10.4103/idoj.IDOJ_303_18
pii: IDOJ-10-272
pmc: PMC6536082
doi:
Types de publication
Journal Article
Langues
eng
Pagination
272-278Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
Diabetes Care. 1999 Oct;22(10):1655-9
pubmed: 10526730
Diabetes Care. 2000 Jan;23(1):57-63
pubmed: 10857969
Diabetes Care. 2000 Mar;23(3):381-9
pubmed: 10868870
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
Diabetes Care. 2004 Jun;27(6):1412-6
pubmed: 15161797
Diabetes Care. 2004 Jun;27(6):1487-95
pubmed: 15161807
Postgrad Med J. 2005 Aug;81(958):541-4
pubmed: 16085750
Arch Dermatol. 1992 Jul;128(7):941-4
pubmed: 1626961
Diabetes Res Clin Pract. 2006 Dec;74(3):289-94
pubmed: 16730847
J Am Acad Dermatol. 2007 Sep;57(3):502-8
pubmed: 17592743
Indian J Dermatol Venereol Leprol. 2002 Mar-Apr;68(2):67-72
pubmed: 17656880
J Paediatr Child Health. 2008 Jun;44(6):338-41
pubmed: 18476925
BMC Pediatr. 2008 Aug 12;8:31
pubmed: 18700035
Arq Bras Endocrinol Metabol. 2009 Mar;53(2):281-7
pubmed: 19466221
Diabetes Res Clin Pract. 2010 Jan;87(1):4-14
pubmed: 19896746
J Clin Endocrinol Metab. 2010 Dec;95(12):5189-98
pubmed: 20829185
J Natl Med Assoc. 2010 Oct;102(10):944-9
pubmed: 21053710
Clin Chem. 2011 Feb;57(2):279-85
pubmed: 21127151
Clin Pediatr (Phila). 2011 Nov;50(11):1057-61
pubmed: 21757774
Gac Med Mex. 2011 Jul-Aug;147(4):297-302
pubmed: 21894227
Indian J Dermatol. 2011 Nov;56(6):678-83
pubmed: 22345770
An Bras Dermatol. 2012 Jul-Aug;87(4):531-7
pubmed: 22892764
Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S436-7
pubmed: 23565457
JAMA Dermatol. 2013 Jul;149(7):875-7
pubmed: 23864088
Ann Dermatol. 2013 Aug;25(3):375-7
pubmed: 24003287
Obes Res Clin Pract. 2008 Mar;2(1):I-II
pubmed: 24351677
J Clin Res Pediatr Endocrinol. 2013;5(4):245-51
pubmed: 24379034
Rev Lat Am Enfermagem. 2013 Nov-Dec;21(6):1220-7
pubmed: 24402337
Hong Kong Med J. 2014 Aug;20(4):290-6
pubmed: 24762331
Indian Pediatr. 2014 Apr;51(4):279-84
pubmed: 24825264
Exp Clin Endocrinol Diabetes. 2015 Jan;123(1):27-33
pubmed: 25314648
Arq Bras Cardiol. 2015 Apr;104(4):266-73
pubmed: 25993589
Clin Dermatol. 2015 Jul-Aug;33(4):466-70
pubmed: 26051063
Curr Opin Endocrinol Diabetes Obes. 2015 Aug;22(4):283-9
pubmed: 26087335
Rev Paul Pediatr. 2016 Jun;34(2):234-42
pubmed: 26559605
Drug Discov Ther. 2015 Dec;9(6):380-5
pubmed: 26781921
Indian J Med Res. 2016 Feb;143(2):160-74
pubmed: 27121514
Curr Diab Rep. 2016 Jul;16(7):64
pubmed: 27179965
Am J Med. 1989 Sep;87(3):269-72
pubmed: 2773965
Indian J Dermatol Venereol Leprol. 2017 Mar-Apr;83(2):190-194
pubmed: 28164885
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825